Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Exacerbation Study (INVIGORATE)

16 de setembro de 2013 atualizado por: Novartis Pharmaceuticals

A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, Parallel Group Efficacy Study Comparing the Effect of Inhaled Indacaterol 150 µg o.d. vs Inhaled Tiotropium 18 µg o.d. on Lung Function, Rate of Exacerbations and Related Outcomes in Patients With COPD

This study compares indacaterol with tiotropium in terms of bronchodilation over 52 weeks

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Real)

3439

Estágio

  • Fase 3

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Bad Woerishofen, Alemanha, 86825
        • Novartis Investigative Site
      • Berlin, Alemanha, 12043
        • Novartis Investigative Site
      • Berlin, Alemanha, 12687
        • Novartis Investigative Site
      • Berlin, Alemanha, 13086
        • Novartis Investigative Site
      • Berlin, Alemanha, 10367
        • Novartis Investigative Site
      • Berlin, Alemanha, 14050
        • Novartis Investigative Site
      • Berlin, Alemanha, 10969
        • Novartis Investigative Site
      • Berlin, Alemanha, 13581
        • Novartis Investigative Site
      • Berlin, Alemanha, 13057
        • Novartis Investigative Site
      • Berlin, Alemanha, 13507
        • Novartis Investigative Site
      • Bonn, Alemanha, 53119
        • Novartis Investigative Site
      • Bonn, Alemanha, 53123
        • Novartis Investigative Site
      • Borstel, Alemanha, 23845
        • Novartis Investigative Site
      • Dachau, Alemanha, 85221
        • Novartis Investigative Site
      • Euskirchen, Alemanha, 53879
        • Novartis Investigative Site
      • Frankfurt, Alemanha, 60596
        • Novartis Investigative Site
      • Fürstenwalde/Spree, Alemanha, 15517
        • Novartis Investigative Site
      • Güstrow, Alemanha, 18273
        • Novartis Investigative Site
      • Hamburg, Alemanha, 20354
        • Novartis Investigative Site
      • Hamburg, Alemanha, 20357
        • Novartis Investigative Site
      • Hamburg, Alemanha, 22299
        • Novartis Investigative Site
      • Hamburg, Alemanha, 22305
        • Novartis Investigative Site
      • Hoyerswerda, Alemanha, 02977
        • Novartis Investigative Site
      • Landsberg, Alemanha, 86899
        • Novartis Investigative Site
      • Leipzig, Alemanha, 04207
        • Novartis Investigative Site
      • Mainz, Alemanha, D-55101
        • Novartis Investigative Site
      • Marburg, Alemanha, 35037
        • Novartis Investigative Site
      • Muenchen, Alemanha, 80331
        • Novartis Investigative Site
      • Muenchen, Alemanha, 80539
        • Novartis Investigative Site
      • Muenchen, Alemanha, 81677
        • Novartis Investigative Site
      • Muenchen, Alemanha, 81243
        • Novartis Investigative Site
      • München, Alemanha, 80335
        • Novartis Investigative Site
      • Neu-Ulm, Alemanha, 89231
        • Novartis Investigative Site
      • Neumünster, Alemanha, 24534
        • Novartis Investigative Site
      • Neuss, Alemanha, 41462
        • Novartis Investigative Site
      • Oranienburg, Alemanha, 16515
        • Novartis Investigative Site
      • Radebeul, Alemanha, 01445
        • Novartis Investigative Site
      • Ratingen, Alemanha, 40878
        • Novartis Investigative Site
      • Rüdersdorf, Alemanha, 15562
        • Novartis Investigative Site
      • Teterow, Alemanha, 17166
        • Novartis Investigative Site
      • Ulm, Alemanha, 89081
        • Novartis Investigative Site
      • Wedel, Alemanha, 22880
        • Novartis Investigative Site
      • Witten, Alemanha, 58452
        • Novartis Investigative Site
      • Buenos Aires, Argentina
        • Novartis Investigative Site
      • Buenos Aires, Argentina, B1842DID
        • Novartis Investigative Site
      • Buenos Aires, Argentina, C1122AAK
        • Novartis Investigative Site
      • Buenos Aires, Argentina, C1125ABE
        • Novartis Investigative Site
      • Buenos Aires, Argentina, 5000
        • Novartis Investigative Site
      • Buenos Aires, Argentina, C1426ABP
        • Novartis Investigative Site
      • Buenos aires, Argentina, C1221ADC
        • Novartis Investigative Site
      • Mendoza, Argentina, M5500CCG
        • Novartis Investigative Site
    • Buenos Aires
      • Capital Federal, Buenos Aires, Argentina, C1424BSF
        • Novartis Investigative Site
      • Mar del Plata, Buenos Aires, Argentina, 7600
        • Novartis Investigative Site
      • Pilar, Buenos Aires, Argentina, B1629AHJ
        • Novartis Investigative Site
    • Santa Fe
      • Rosario, Santa Fe, Argentina, C2000DSR
        • Novartis Investigative Site
      • Rosario, Santa Fe, Argentina, S2000AYW
        • Novartis Investigative Site
    • Tucuman
      • San Miguel de Tucuman, Tucuman, Argentina, 4000
        • Novartis Investigative Site
      • Tauranga, New Zealand, Austrália, 3001
        • Novartis Investigative Site
    • New South Wales
      • Bankstown, New South Wales, Austrália, 2200
        • Novartis Investigative Site
    • South Australia
      • Adelaide, South Australia, Austrália, 5000
        • Novartis Investigative Site
      • Daw Park, South Australia, Austrália, 5041
        • Novartis Investigative Site
    • Victoria
      • Heidelberg, Victoria, Austrália, 3084
        • Novartis Investigative Site
      • Parkville, Victoria, Austrália, 3050
        • Novartis Investigative Site
    • Western Australia
      • Nedlands, Western Australia, Austrália, 6009
        • Novartis Investigative Site
    • GO
      • Goiania, GO, Brasil, 74605-050
        • Novartis Investigative Site
    • MG
      • Juiz de Fora, MG, Brasil, 36036-110
        • Novartis Investigative Site
    • RJ
      • Rio de Janeiro, RJ, Brasil, 22271-110
        • Novartis Investigative Site
    • RS
      • Caxias do Sul, RS, Brasil, 95070-560
        • Novartis Investigative Site
      • Porto Alegre, RS, Brasil, 90020-090
        • Novartis Investigative Site
      • Porto Alegre, RS, Brasil, 90610-000
        • Novartis Investigative Site
      • Porto Alegre, RS, Brasil, 90880-480
        • Novartis Investigative Site
    • SP
      • São Paulo, SP, Brasil, 04023-062
        • Novartis Investigative Site
      • Aalst, Bélgica, 9300
        • Novartis Investigative Site
      • Antwerpen, Bélgica, 2020
        • Novartis Investigative Site
      • Bruxelles, Bélgica, 1200
        • Novartis Investigative Site
      • Bruxelles, Bélgica, 1000
        • Novartis Investigative Site
      • Duffel, Bélgica, 2570
        • Novartis Investigative Site
      • Eupen, Bélgica, 4700
        • Novartis Investigative Site
      • Framerie, Bélgica, 7080
        • Novartis Investigative Site
      • Geraardsbergen, Bélgica, 9500
        • Novartis Investigative Site
      • Gilly, Bélgica, 6060
        • Novartis Investigative Site
      • Godinne, Bélgica, 5530
        • Novartis Investigative Site
      • Gozée, Bélgica, 6534
        • Novartis Investigative Site
      • Herentals, Bélgica, 2200
        • Novartis Investigative Site
      • Jambes, Bélgica, 5100
        • Novartis Investigative Site
      • Jette, Bélgica, 1090
        • Novartis Investigative Site
      • Kortrijk, Bélgica, 8500
        • Novartis Investigative Site
      • Leuven, Bélgica, 3000
        • Novartis Investigative Site
      • Liege, Bélgica, 4000
        • Novartis Investigative Site
      • Liège, Bélgica, 4000
        • Novartis Investigative Site
      • Malmedy, Bélgica, 4960
        • Novartis Investigative Site
      • Menen, Bélgica, 8930
        • Novartis Investigative Site
      • Montigny-le-tilleul, Bélgica, 6110
        • Novartis Investigative Site
      • Namur, Bélgica, 5000
        • Novartis Investigative Site
      • Oostende, Bélgica, 8400
        • Novartis Investigative Site
      • Turnhout, Bélgica, 2300
        • Novartis Investigative Site
    • Alberta
      • Calgary, Alberta, Canadá, T2N 4N1
        • Novartis Investigative Site
      • Calgary, Alberta, Canadá, T2V 1P9
        • Novartis Investigative Site
      • Edmonton, Alberta, Canadá, T6G 2B7
        • Novartis Investigative Site
    • British Columbia
      • Kelowna, British Columbia, Canadá, V1Y 1E4
        • Novartis Investigative Site
      • Vancouver, British Columbia, Canadá, V5Z 3J5
        • Novartis Investigative Site
    • Manitoba
      • Winnipeg, Manitoba, Canadá, R3C 0N2
        • Novartis Investigative Site
    • New Brunswick
      • Moncton, New Brunswick, Canadá, E1G 1A7
        • Novartis Investigative Site
    • Ontario
      • Burlington, Ontario, Canadá, L7N 3V2
        • Novartis Investigative Site
      • Mississauga, Ontario, Canadá, L5B 4A9
        • Novartis Investigative Site
      • Newmarket, Ontario, Canadá, L3Y 5G8
        • Novartis Investigative Site
      • Ottawa, Ontario, Canadá, K1Y 4G2
        • Novartis Investigative Site
      • Toronto, Ontario, Canadá, M6H 3M2
        • Novartis Investigative Site
      • Toronto, Ontario, Canadá, M5T 3A9
        • Novartis Investigative Site
      • Toronto, Ontario, Canadá, M5G1N8
        • Novartis Investigative Site
    • Quebec
      • Montreal, Quebec, Canadá, H2L 4M1
        • Novartis Investigative Site
      • Montreal, Quebec, Canadá, H4J 1C5
        • Novartis Investigative Site
      • Montreal, Quebec, Canadá, H2L 2W5
        • Novartis Investigative Site
      • Montreal, Quebec, Canadá, H2X 2P4
        • Novartis Investigative Site
      • Sainte-Foy, Quebec, Canadá, G1V 4G5
        • Novartis Investigative Site
      • Sherbrooke, Quebec, Canadá, J1H 4J6
        • Novartis Investigative Site
      • Beijing, China, 100020
        • Novartis Investigative Site
      • Beijing, China, 100034
        • Novartis Investigative Site
      • Chongqing, China, 400037
        • Novartis Investigative Site
      • Shanghai, China, 200025
        • Novartis Investigative Site
      • Shen Yang, China, 110001
        • Novartis Investigative Site
    • Hebei
      • Shijiazhuang, Hebei, China, 050000
        • Novartis Investigative Site
    • Hunan
      • Changsha, Hunan, China, 410003
        • Novartis Investigative Site
      • Changsha City, Hunan, China, 410011
        • Novartis Investigative Site
    • Liaoning
      • Shengyang, Liaoning, China, 110016
        • Novartis Investigative Site
    • Shanxi
      • Xi'an, Shanxi, China, 710032
        • Novartis Investigative Site
      • Xi'an, Shanxi, China, 710061
        • Novartis Investigative Site
      • Barranquilla, Colômbia
        • Novartis Investigative Site
      • Bogotá, Colômbia
        • Novartis Investigative Site
      • Medellín, Colômbia
        • Novartis Investigative Site
      • San Francisco de Asís, Costa Rica
        • Novartis Investigative Site
      • San Jose, Costa Rica
        • Novartis Investigative Site
      • Aalborg, Dinamarca, DK-9100
        • Novartis Investigative Site
      • Copenhagen NV, Dinamarca, DK-2400
        • Novartis Investigative Site
      • Hellerup, Dinamarca, DK-2900
        • Novartis Investigative Site
      • Helsingor, Dinamarca, DK-3000
        • Novartis Investigative Site
      • Hvidovre, Dinamarca, DK-2650
        • Novartis Investigative Site
      • Odense C, Dinamarca, DK-5000
        • Novartis Investigative Site
      • Århus, Dinamarca, DK-8000
        • Novartis Investigative Site
      • Bratislava, Eslováquia, 826 06
        • Novartis Investigative Site
      • Kosice, Eslováquia, 040 01
        • Novartis Investigative Site
      • Lucenec, Eslováquia, 984 39
        • Novartis Investigative Site
      • Nove Zamky, Eslováquia, 940 01
        • Novartis Investigative Site
      • Poprad, Eslováquia, 058 01
        • Novartis Investigative Site
    • Slovak Republic
      • Bratislava, Slovak Republic, Eslováquia, 821 06
        • Novartis Investigative Site
      • Kosice, Slovak Republic, Eslováquia, 041 90
        • Novartis Investigative Site
      • Spisska Nova Ves, Slovak Republic, Eslováquia, 052 01
        • Novartis Investigative Site
      • Madrid, Espanha, 28007
        • Novartis Investigative Site
      • Madrid, Espanha, 28040
        • Novartis Investigative Site
    • Andalucia
      • Jerez de La Frontera, Andalucia, Espanha, 11407
        • Novartis Investigative Site
      • Malaga, Andalucia, Espanha, 29010
        • Novartis Investigative Site
      • Sanlúcar de Barrameda, Andalucia, Espanha, 11540
        • Novartis Investigative Site
      • Sevilla, Andalucia, Espanha, 41009
        • Novartis Investigative Site
    • Asturias
      • Gijon, Asturias, Espanha, 33290
        • Novartis Investigative Site
    • Castilla la Mancha
      • Illescas, Castilla la Mancha, Espanha, 45200
        • Novartis Investigative Site
    • Castilla y Leon
      • Valladolid, Castilla y Leon, Espanha, 47011
        • Novartis Investigative Site
    • Cataluña
      • Barcelona, Cataluña, Espanha, 08003
        • Novartis Investigative Site
      • Barcelona, Cataluña, Espanha, 08041
        • Novartis Investigative Site
      • Barcelona, Cataluña, Espanha, 08036
        • Novartis Investigative Site
      • Salt, Cataluña, Espanha, 17190
        • Novartis Investigative Site
      • Sant Boi de Llobregat, Cataluña, Espanha, 08830
        • Novartis Investigative Site
      • Terrassa, Cataluña, Espanha, 08221
        • Novartis Investigative Site
      • Vic, Cataluña, Espanha, 08500
        • Novartis Investigative Site
    • Comunidad Valenciana
      • Alicante, Comunidad Valenciana, Espanha, 03114
        • Novartis Investigative Site
      • Alzira, Comunidad Valenciana, Espanha, 46600
        • Novartis Investigative Site
      • Requena, Comunidad Valenciana, Espanha, 46340
        • Novartis Investigative Site
    • Extremadura
      • Caceres, Extremadura, Espanha, 10003
        • Novartis Investigative Site
      • Mérida, Extremadura, Espanha, 06800
        • Novartis Investigative Site
      • Plasencia, Extremadura, Espanha, 10600
        • Novartis Investigative Site
    • Galicia
      • La Coruna, Galicia, Espanha, 15006
        • Novartis Investigative Site
      • Lugo, Galicia, Espanha, 27003
        • Novartis Investigative Site
      • Santiago de Compostela, Galicia, Espanha, 15706
        • Novartis Investigative Site
    • Madrid
      • Pozuelo de Alarcón, Madrid, Espanha, 28223
        • Novartis Investigative Site
      • Rakvere, Estônia, 44310
        • Novartis Investigative Site
      • Tallinn, Estônia, 13619
        • Novartis Investigative Site
      • Tartu, Estônia, 51014
        • Novartis Investigative Site
      • Chelyabinsk, Federação Russa, 454021
        • Novartis Investigative Site
      • Chelyabinsk, Federação Russa, 454047
        • Novartis Investigative Site
      • Ekaterinburg, Federação Russa, 620109
        • Novartis Investigative Site
      • Ekaterinburg, Federação Russa, 620219
        • Novartis Investigative Site
      • Kazan, Federação Russa, 420015
        • Novartis Investigative Site
      • Moscow, Federação Russa, 121359
        • Novartis Investigative Site
      • Moscow, Federação Russa, 105229
        • Novartis Investigative Site
      • Moscow, Federação Russa, 119992
        • Novartis Investigative Site
      • Moscow, Federação Russa, 115280
        • Novartis Investigative Site
      • Moscow, Federação Russa, 105077
        • Novartis Investigative Site
      • Moscow, Federação Russa, 115446
        • Novartis Investigative Site
      • Moscow, Federação Russa, 121609
        • Novartis Investigative Site
      • Samara, Federação Russa, 443079
        • Novartis Investigative Site
      • Sankt-Peterburg, Federação Russa, 197022
        • Novartis Investigative Site
      • St. Petersburg, Federação Russa, 194354
        • Novartis Investigative Site
      • St.-Petersburg, Federação Russa, 193231
        • Novartis Investigative Site
    • Tatarstan Republic
      • Kazan, Tatarstan Republic, Federação Russa, 420015
        • Novartis Investigative Site
      • Quezon City, Filipinas, 1100
        • Novartis Investigative Site
      • Quezon City, Filipinas, 1101
        • Novartis Investigative Site
    • Metro Manila
      • Quezon City, Metro Manila, Filipinas, 1109
        • Novartis Investigative Site
      • Quezon City, Metro Manila, Filipinas, 1104
        • Novartis Investigative Site
      • HUS, Finlândia, 00029
        • Novartis Investigative Site
      • Helsinki, Finlândia, 00029
        • Novartis Investigative Site
      • Jyvaskyla, Finlândia, 40100
        • Novartis Investigative Site
      • Pori, Finlândia, FIN-28500
        • Novartis Investigative Site
      • Porvoo, Finlândia, FIN-06200
        • Novartis Investigative Site
      • Tampere, Finlândia, FIN-33521
        • Novartis Investigative Site
      • Turku, Finlândia, FIN-20100
        • Novartis Investigative Site
      • Beuvry, França, 62660
        • Novartis Investigative Site
      • Bourges, França, 18000
        • Novartis Investigative Site
      • Ferolles-Attily, França, 77150
        • Novartis Investigative Site
      • Lyon cedex 04, França, 69317
        • Novartis Investigative Site
      • Montpellier, França, 34059
        • Novartis Investigative Site
      • Nantes, França, 44000
        • Novartis Investigative Site
      • Nice Cedex 1, França, 06602
        • Novartis Investigative Site
      • Ollioules Cedex, França, 83192
        • Novartis Investigative Site
      • Paris, França, 75006
        • Novartis Investigative Site
      • Perpignan Cedex, França, 66025
        • Novartis Investigative Site
      • Pessac, França, 33604
        • Novartis Investigative Site
      • Reims, França, 51092
        • Novartis Investigative Site
      • St Michel, França, 16470
        • Novartis Investigative Site
      • Vandoeuvre les Nancy, França, 54511
        • Novartis Investigative Site
      • Almelo, Holanda, 7609 PP
        • Novartis Investigative Site
      • Breda, Holanda, 4819 EV
        • Novartis Investigative Site
      • Eindhoven, Holanda, 5623 EJ
        • Novartis Investigative Site
      • Enschede, Holanda, 7513 ER
        • Novartis Investigative Site
      • Rotterdam, Holanda, 3045 PM
        • Novartis Investigative Site
      • Sneek, Holanda, 8601 ZK
        • Novartis Investigative Site
      • Zwolle, Holanda, 8011 JW
        • Novartis Investigative Site
      • Budapest, Hungria, 1125
        • Novartis Investigative Site
      • Cegled, Hungria, 2700
        • Novartis Investigative Site
      • Debrecen, Hungria, 4032
        • Novartis Investigative Site
      • Deszk, Hungria, 6772
        • Novartis Investigative Site
      • Mosonmagyarovar, Hungria, 9200
        • Novartis Investigative Site
      • Nyiregyhaza, Hungria, 4400
        • Novartis Investigative Site
      • Sopron, Hungria, 9400
        • Novartis Investigative Site
      • Szarvas, Hungria, 5540
        • Novartis Investigative Site
      • Tatabanya, Hungria, 2800
        • Novartis Investigative Site
      • Torokbalint, Hungria, 2045
        • Novartis Investigative Site
      • Reykjavik, Islândia, IS-109
        • Novartis Investigative Site
      • Ashkelon, Israel, 78278
        • Novartis Investigative Site
      • Jerusalem, Israel, 91120
        • Novartis Investigative Site
      • Ramat Gan, Israel, 52621
        • Novartis Investigative Site
      • Rehovot, Israel, 76100
        • Novartis Investigative Site
      • Tel-Aviv, Israel, 64239
        • Novartis Investigative Site
      • Napoli, Itália, 80131
        • Novartis Investigative Site
      • Pisa, Itália, 56124
        • Novartis Investigative Site
    • BA
      • Acquaviva delle Fonti, BA, Itália, 70021
        • Novartis Investigative Site
      • Bari, BA, Itália, 70124
        • Novartis Investigative Site
    • BG
      • Bergamo, BG, Itália, 24128
        • Novartis Investigative Site
    • BS
      • Brescia, BS, Itália, 25127
        • Novartis Investigative Site
    • CZ
      • Catanzaro, CZ, Itália, 88100
        • Novartis Investigative Site
    • FE
      • Cona, FE, Itália, 44100
        • Novartis Investigative Site
    • FR
      • Cassino, FR, Itália, 03043
        • Novartis Investigative Site
    • GE
      • Genova, GE, Itália, 16132
        • Novartis Investigative Site
    • MI
      • Milano, MI, Itália, 20142
        • Novartis Investigative Site
      • Milano, MI, Itália, 20126
        • Novartis Investigative Site
      • Milano, MI, Itália, 20157
        • Novartis Investigative Site
    • MO
      • Modena, MO, Itália, 41100
        • Novartis Investigative Site
    • PA
      • Palermo, PA, Itália, 90146
        • Novartis Investigative Site
    • PN
      • Pordenone, PN, Itália, 33170
        • Novartis Investigative Site
    • PO
      • Prato, PO, Itália, 59100
        • Novartis Investigative Site
    • PR
      • Parma, PR, Itália, 43100
        • Novartis Investigative Site
    • RM
      • Roma, RM, Itália, 00168
        • Novartis Investigative Site
      • Roma, RM, Itália, 00161
        • Novartis Investigative Site
      • Roma, RM, Itália, 00133
        • Novartis Investigative Site
      • Roma, RM, Itália, 00163
        • Novartis Investigative Site
    • SA
      • Cava Dei Tirreni, SA, Itália, 84013
        • Novartis Investigative Site
    • SI
      • Siena, SI, Itália, 53100
        • Novartis Investigative Site
    • TE
      • Teramo, TE, Itália, 64100
        • Novartis Investigative Site
    • TO
      • Orbassano, TO, Itália, 10043
        • Novartis Investigative Site
    • TS
      • Trieste, TS, Itália, 34149
        • Novartis Investigative Site
    • VA
      • Cuasso al Monte, VA, Itália, 21050
        • Novartis Investigative Site
    • VR
      • Verona, VR, Itália, 37126
        • Novartis Investigative Site
      • Riga, Letônia, 1002
        • Novartis Investigative Site
    • LV
      • Riga, LV, Letônia, LV-1038
        • Novartis Investigative Site
      • Kaunas, Lituânia, 44320
        • Novartis Investigative Site
      • Klaipeda, Lituânia, LT-92231
        • Novartis Investigative Site
      • Siauliai, Lituânia, LT-76231
        • Novartis Investigative Site
      • Utena, Lituânia, LT-28151
        • Novartis Investigative Site
      • Vilnius, Lituânia, LT-08661
        • Novartis Investigative Site
      • San Luis Potosí, México, 78218
        • Novartis Investigative Site
    • Hidalgo
      • Pachuca, Hidalgo, México, 42090
        • Novartis Investigative Site
    • Jalisco
      • Guadalajara, Jalisco, México, 44100
        • Novartis Investigative Site
      • Guadalajara, Jalisco, México, 44280
        • Novartis Investigative Site
    • Nuevo León
      • Monterrey, Nuevo León, México, 64450
        • Novartis Investigative Site
      • Ankara, Peru, 06100
        • Novartis Investigative Site
      • Canakkale, Peru, 17100
        • Novartis Investigative Site
      • Diskapi / Ankara, Peru, 06110
        • Novartis Investigative Site
      • Emek / Ankara, Peru, 06510
        • Novartis Investigative Site
      • Gaziantep, Peru, 27070
        • Novartis Investigative Site
      • Isparta, Peru, 32100
        • Novartis Investigative Site
      • Istanbul, Peru
        • Novartis Investigative Site
      • Izmir, Peru, 35340
        • Novartis Investigative Site
      • Kahramanmaras, Peru, 46100
        • Novartis Investigative Site
      • Kecioren / Ankara, Peru, 06280
        • Novartis Investigative Site
      • Kozlu / Zonguldak, Peru, 67600
        • Novartis Investigative Site
      • Malatya, Peru, 44280
        • Novartis Investigative Site
      • Mersin, Peru, 33079
        • Novartis Investigative Site
      • Yenisehir/Izmir, Peru, 35110
        • Novartis Investigative Site
    • Lima
      • Cercado de Lima, Lima, Peru, 01
        • Novartis Investigative Site
      • Jesus Maria, Lima, Peru, 11
        • Novartis Investigative Site
      • La Victoria, Lima, Peru, 13
        • Novartis Investigative Site
      • Miraflores, Lima, Peru, 18
        • Novartis Investigative Site
      • San Borja, Lima, Peru, 41
        • Novartis Investigative Site
      • San Isidro, Lima, Peru, 27
        • Novartis Investigative Site
      • San Martin de Porres, Lima, Peru, 31
        • Novartis Investigative Site
      • San Miguel, Lima, Peru, 32
        • Novartis Investigative Site
      • Santiago de Surco, Lima, Peru, 33
        • Novartis Investigative Site
      • Gdansk, Polônia, 80-169
        • Novartis Investigative Site
      • Gdansk, Polônia, 80-847
        • Novartis Investigative Site
      • Katowice, Polônia, 40-752
        • Novartis Investigative Site
      • Krakow, Polônia, 31-159
        • Novartis Investigative Site
      • Krakow, Polônia, 31-202
        • Novartis Investigative Site
      • Krakow, Polônia, 31-455
        • Novartis Investigative Site
      • Warszawa, Polônia, 02-341
        • Novartis Investigative Site
      • Warszawa, Polônia, 01-138
        • Novartis Investigative Site
      • Wroclaw, Polônia, 50-044
        • Novartis Investigative Site
      • Amadora, Portugal, 2720-276
        • Novartis Investigative Site
      • Coimbra, Portugal, 3000-075
        • Novartis Investigative Site
      • Coimbra, Portugal, 3041-853
        • Novartis Investigative Site
      • Lisboa, Portugal, 1649-035
        • Novartis Investigative Site
      • Lisboa, Portugal, 1169-024
        • Novartis Investigative Site
      • Lisboa, Portugal, 1769-001
        • Novartis Investigative Site
      • Porto, Portugal, 4200-319
        • Novartis Investigative Site
      • Belfast, Reino Unido, BT7 2BE
        • Novartis Investigative Site
      • Bexhill-on-Sea, Reino Unido, TN40 1JJ
        • Novartis Investigative Site
      • Bradford, Reino Unido, BD9 6RJ
        • Novartis Investigative Site
      • Bristol, Reino Unido, BS10 5NB
        • Novartis Investigative Site
      • Cambridge, Reino Unido, CB7 5JD
        • Novartis Investigative Site
      • Lancashire, Reino Unido, FY3 7EN
        • Novartis Investigative Site
      • Lancashire, Reino Unido, B13 6TL
        • Novartis Investigative Site
      • Liverpool, Reino Unido, L9 7AL
        • Novartis Investigative Site
      • London, Reino Unido, SW3 6PH
        • Novartis Investigative Site
      • London, Reino Unido, E2 9JX
        • Novartis Investigative Site
      • London, Reino Unido, W1G 8HU
        • Novartis Investigative Site
      • Newport, Reino Unido, P030 5TG
        • Novartis Investigative Site
      • Stockport, Reino Unido, SK4 4NX
        • Novartis Investigative Site
      • Stockport, Reino Unido, SK8 6LU
        • Novartis Investigative Site
      • Surrey, Reino Unido, KT16 0PZ
        • Novartis Investigative Site
      • Warminster, Reino Unido, BA12 9AA
        • Novartis Investigative Site
      • Watford, Reino Unido, WD25 0EA
        • Novartis Investigative Site
      • Windsor, Reino Unido, SL4 3DP
        • Novartis Investigative Site
    • England
      • Swansea, England, Reino Unido, SA6 6NL
        • Novartis Investigative Site
    • Newcastle
      • Newcastle Upon Tyne, Newcastle, Reino Unido, NE7 7DN
        • Novartis Investigative Site
    • Surrey
      • Ash Vale, Surrey, Reino Unido, GU12 5BA
        • Novartis Investigative Site
    • West Sussex
      • Crawley, West Sussex, Reino Unido, RH10 7DX
        • Novartis Investigative Site
      • Beroun, República Checa
        • Novartis Investigative Site
      • Ceske Budejovice, República Checa, 370 87
        • Novartis Investigative Site
      • Cesky Krumlov, República Checa, 381 01
        • Novartis Investigative Site
      • Cvikov, República Checa, 471 54
        • Novartis Investigative Site
      • Karlovy Vary, República Checa, 360 66
        • Novartis Investigative Site
      • Karlovy Vary, República Checa, 360 06
        • Novartis Investigative Site
      • Kurim, República Checa, 66434
        • Novartis Investigative Site
      • Novy Jicin, República Checa, 741 01
        • Novartis Investigative Site
      • Ostrava, República Checa, 70030
        • Novartis Investigative Site
      • Ostrava - Hrabuvka, República Checa, 70030
        • Novartis Investigative Site
      • Praha 6, República Checa, 169 00
        • Novartis Investigative Site
      • Prerov, República Checa, 75000
        • Novartis Investigative Site
      • Rokycany, República Checa, 337 22
        • Novartis Investigative Site
      • Rudna, República Checa, 25219
        • Novartis Investigative Site
      • Strakonice, República Checa, 38601
        • Novartis Investigative Site
      • Teplice, República Checa, 415 01
        • Novartis Investigative Site
      • Zatec, República Checa, 438 01
        • Novartis Investigative Site
    • CZE
      • Kyjov, CZE, República Checa, 697 70
        • Novartis Investigative Site
      • Bucharest, Romênia, 060011
        • Novartis Investigative Site
      • Cluj-Napoca, Romênia, 400371
        • Novartis Investigative Site
    • District 3
      • Bucharest, District 3, Romênia, 030303
        • Novartis Investigative Site
    • Jud. Brasov
      • Brasov, Jud. Brasov, Romênia, 500118
        • Novartis Investigative Site
    • Jud. Constanta
      • Constanta, Jud. Constanta, Romênia, 900002
        • Novartis Investigative Site
    • Jud. Iasi
      • Iasi, Jud. Iasi, Romênia, 700115
        • Novartis Investigative Site
      • Göteborg, Suécia, 413 45
        • Novartis Investigative Site
      • Göteborg, Suécia, 412 63
        • Novartis Investigative Site
      • Luleå, Suécia, SE-971 80
        • Novartis Investigative Site
      • Lund, Suécia, SE-221 85
        • Novartis Investigative Site
      • Malmö, Suécia, 205 02
        • Novartis Investigative Site
      • Skellefteå, Suécia, SE 931 32
        • Novartis Investigative Site
      • Stockholm, Suécia, S-171 76
        • Novartis Investigative Site
      • Sundsvall, Suécia, 851 86
        • Novartis Investigative Site
      • Bern, Suíça, 3013
        • Novartis Investigative Site
      • Crans-Montana, Suíça, 3963
        • Novartis Investigative Site
      • Lausanne, Suíça, 1011
        • Novartis Investigative Site
      • St. Gallen, Suíça, 9007
        • Novartis Investigative Site
      • Thun, Suíça, 3600
        • Novartis Investigative Site
      • Winterthur, Suíça, 8401
        • Novartis Investigative Site
      • Zuerich, Suíça, 8032
        • Novartis Investigative Site
    • ZH
      • Faltigberg-Wald, ZH, Suíça, 8639
        • Novartis Investigative Site
      • Bangkok, Tailândia, 10700
        • Novartis Investigative Site
      • Chiang Mai, Tailândia, 50200
        • Novartis Investigative Site
      • Khon Kaen, Tailândia, 40002
        • Novartis Investigative Site
      • Songkla, Tailândia, 90110
        • Novartis Investigative Site
      • Taichung, Taiwan, 40447
        • Novartis Investigative Site
      • Taichung, Taiwan, 40705
        • Novartis Investigative Site
      • Taipei, Taiwan, 10002
        • Novartis Investigative Site
      • Taipei, Taiwan, 110
        • Novartis Investigative Site
      • Taipei County, Taiwan
        • Novartis Investigative Site
    • Estado Carabobo
      • Valencia, Estado Carabobo, Venezuela, 2005
        • Novartis Investigative Site
    • Estado Lara
      • Barquisimeto, Estado Lara, Venezuela, 3002
        • Novartis Investigative Site
    • Estado Zulia
      • Maracaibo, Estado Zulia, Venezuela, 4002
        • Novartis Investigative Site
      • Bloemfontein, África do Sul, 9301
        • Novartis Investigative Site
      • Bloemfontein, África do Sul, 9317
        • Novartis Investigative Site
      • Cape Town, África do Sul, 8001
        • Novartis Investigative Site
      • Durban, África do Sul, 4001
        • Novartis Investigative Site
      • Feldbach, Áustria, 8330
        • Novartis Investigative Site
      • Grieskirchen, Áustria, 4710
        • Novartis Investigative Site
      • Gänserndorf, Áustria, 2230
        • Novartis Investigative Site
      • Hallein, Áustria, 5400
        • Novartis Investigative Site
      • Linz, Áustria, 4020
        • Novartis Investigative Site
      • Perg, Áustria, 4320
        • Novartis Investigative Site
      • Zwettl, Áustria, 3910
        • Novartis Investigative Site
      • Nagpur - Maharashtra, Índia, 440012
        • Novartis Investigative Site
      • Nagpur - Maharastra, Índia, 400 012
        • Novartis Investigative Site
      • Panjim, Índia, 403002
        • Novartis Investigative Site
    • Andhra Pradesh
      • Hyderabad, Andhra Pradesh, Índia, 500004
        • Novartis Investigative Site
      • Hyderabad, Andhra Pradesh, Índia, 500012
        • Novartis Investigative Site
    • Delhi
      • New Delhi, Delhi, Índia, 110029
        • Novartis Investigative Site
    • Gujrat
      • Ahmedabad, Gujrat, Índia, 380009
        • Novartis Investigative Site
    • Gujrat-India
      • Ahmedabad, Gujrat-India, Índia, 380054
        • Novartis Investigative Site
    • Karnataka
      • Bangalore, Karnataka, Índia, 560002
        • Novartis Investigative Site
      • Bangalore, Karnataka, Índia, 560 002
        • Novartis Investigative Site
      • Mangalore, Karnataka, Índia, 575001
        • Novartis Investigative Site
    • Kerala
      • Calicut, Kerala, Índia, 673008
        • Novartis Investigative Site
      • Trivandrum, Kerala, Índia, 695011
        • Novartis Investigative Site
    • Madhya Pradesh
      • Indore, Madhya Pradesh, Índia, 452001
        • Novartis Investigative Site
    • New Delhi
      • Noida, New Delhi, Índia, 201301
        • Novartis Investigative Site
    • Rajasthan
      • Jaipur, Rajasthan, Índia, 302023
        • Novartis Investigative Site
    • Tamil Nadu
      • Coimbatore, Tamil Nadu, Índia, 641 002
        • Novartis Investigative Site
      • Vellore, Tamil Nadu, Índia, 632004
        • Novartis Investigative Site

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

40 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Male and female adults aged ≥40 years, who have signed an Informed Consent form prior to initiation of any study-related procedure
  • Patients diagnosed with COPD at age 40 and over and with a current diagnosis of severe COPD and including:

    1. Smoking history of at least 10 pack years, both current and ex-smokers are eligible
    2. A documented history of at least 1 moderate or severe exacerbation in the previous 12 months

Exclusion Criteria:

  • Patients who have received systemic corticosteroids and/or antibiotics for a COPD exacerbation in the 6 weeks prior to screening or during the run-in period
  • Patients who have had a respiratory tract infection within 6 weeks prior to screening
  • Patients with concomitant pulmonary disease
  • Patients with a history of asthma
  • Patients with diabetes Type I or uncontrolled diabetes Type II
  • Any patient with lung cancer or a history of lung cancer
  • Patients with a history of certain cardiovascular comorbid conditions

Other protocol-defined inclusion/exclusion criteria may apply

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Quadruplicar

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Indacaterol
Indacaterol 150 µg o.d. delivered via single-dose dry powder inhaler (SDDPI)
Indacaterol 150 µg o.d. delivered via SDDPI
Comparador Ativo: Tiotropium
Tiotropium 18 µg o.d. delivered via the handihaler®
Tiotropium 18 µg o.d. delivered via handihaler®

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Trough Forced Expiratory Volume in 1 Second (FEV1).
Prazo: 12 weeks
The primary objective of the study was to demonstrate the non-inferiority of indacaterol vs. tiotropium with respect to 24 hour post dose (trough) FEV1 after 12 weeks of treatment in patients with severe COPD. Trough FEV1 was defined as the average of the 23 hours 10 min and the 23 hours 45 min post dose values. Trough FEV1 was analyzed using a mixed model for the PPS-S. The model contained treatment as a fixed effect with the baseline FEV1, FEV1 prior to inhalation and FEV1 15 min post-inhalation of salbutamol/albuterol (components of SABA reversibility at Visit 2), FEV1 prior to inhalation and FEV1 60 min post-inhalation of ipratropium (components of anti-cholinergic reversibility at Visit 3) as covariates. Smoking history (current or ex-smoker) was included as a factor in the model.
12 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Rate of COPD Exacerbations
Prazo: 52 weeks
COPD exacerbations were defined as :Worsening of 2 or more major symptoms for at least 2 consecutive days: dyspnea; sputum volume; suputum purulence AND requiring treatment with systemic corticosteroids and/or antibiotics OR Worsening of any 1 major symptom together with any 1 of the following minor symptoms for at least 2 consecutive days: Sore throat; colds; fever without other cause; increased cough; increase wheeze AND requiring treatment with systemic glucocorticosteroids and/or antibiotics. The rate was analyzed using a linear model assuming a negative binomial distribution for the PPS-E. The time at risk for a patient was defined as the length of time the patient was in the study and the log(length of time in the study) was used as the offset variable in the model.
52 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de março de 2009

Conclusão Primária (Real)

1 de julho de 2012

Conclusão do estudo (Real)

1 de julho de 2012

Datas de inscrição no estudo

Enviado pela primeira vez

15 de fevereiro de 2009

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de fevereiro de 2009

Primeira postagem (Estimativa)

18 de fevereiro de 2009

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

19 de novembro de 2013

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de setembro de 2013

Última verificação

1 de setembro de 2013

Mais Informações

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever